Status:

UNKNOWN

The Diagnosis and Prognosis of Nonpalpable Breast Cancer Detected by the US vs Mammography: a Clinical Noninferiority Trial.

Lead Sponsor:

The First Affiliated Hospital of the Fourth Military Medical University

Conditions:

Breast Cancer

Eligibility:

FEMALE

18+ years

Brief Summary

To evaluate and compare the sensitivity, specificity, AUC, pathology results of core needle biopsy and surgical pathology results coincidence rate, tumor staging, and DFS (disease-free survival) of US...

Eligibility Criteria

Inclusion

  • Women aged 18 years and over with full capacity for civil conduct;
  • Breast imaging examination (including mammography and breast ultrasound) found that patients with BI-RADS 4 or nonpalpable lesion need to have breast biopsy (refer to the classification of BI-RADS, which is consistent with the indications for biopsy), including some patients with BI-RADS 3 nonpalpable breast lesions who are willing to have biopsy;
  • Voluntarily participate in and sign the informed consent form, and be willing to accept the inspection designated by this test;
  • The results of blood examination, coagulation examination, preoperative infection examination, and 12 lead ECG examination within 2 weeks before biopsy met the biopsy requirements;
  • It conforms to the biopsy standard (refer to the image-guided breast histology biopsy guide in the breast cancer diagnosis and treatment guide and specification of China Anti Cancer Association (2019 version)).

Exclusion

  • Women are participating in another clinical trial of drug or medical device;
  • Women with neuropsychiatric disorders;
  • Women with severe systemic diseases and serious bleeding diseases that can not cooperate with the examination, or the researchers think it is not suitable to participate in this clinical trial;
  • Other subjects not suitable for X-ray examination

Key Trial Info

Start Date :

April 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

March 31 2023

Estimated Enrollment :

1277 Patients enrolled

Trial Details

Trial ID

NCT04360616

Start Date

April 1 2020

End Date

March 31 2023

Last Update

January 25 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The First Affiliated Hospital of Fourth Military Medical University

Xi'an, Shaanxi, China, 710000